Beijing Konruns Pharmaceutical Co., Ltd.

Beijing Konruns Pharmaceutical Co., Ltd. logo
🇨🇳China
Ownership
Public
Established
2003-09-03
Employees
447
Market Cap
-
Website
http://www.konruns.cn

A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2024-08-21
Last Posted Date
2024-08-23
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
30
Registration Number
NCT06564272
Locations
🇨🇳

Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, Beijing, China

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

First Posted Date
2024-01-08
Last Posted Date
2024-03-07
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
490
Registration Number
NCT06194734
Locations
🇨🇳

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2023-08-01
Last Posted Date
2024-10-17
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
414
Registration Number
NCT05970783
Locations
🇨🇳

Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, Beijing, China

A Study of KC1036 in Patients with Advanced Thymic Tumors

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2023-01-13
Last Posted Date
2024-10-17
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
30
Registration Number
NCT05683886
Locations
🇨🇳

Shanghai Chest Hospital, Shanghai, Shanghai, China

🇨🇳

West China Hospital, Chengdu, Sichuan, China

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

First Posted Date
2022-07-15
Last Posted Date
2022-07-15
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
180
Registration Number
NCT05460546
Locations
🇨🇳

Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, Beijing, China

A Food Effect Study of KC1036 in Healthy Subjects

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2022-03-03
Last Posted Date
2023-10-10
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
12
Registration Number
NCT05265338
Locations
🇨🇳

West China Hospital of Sichuan University, Chengdu, Sichuan, China

To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2022-03-02
Last Posted Date
2024-10-17
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
133
Registration Number
NCT05260385
Locations
🇨🇳

The first affiliated hospital of bengbu medical college, Bengbu, China

🇨🇳

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China

🇨🇳

Chongqing University Three Gorges Hospital, Chongqing, China

and more 10 locations

A Study of KC1036 in Patients with Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2020-05-14
Last Posted Date
2024-10-17
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
207
Registration Number
NCT04387916
Locations
🇨🇳

ChongQing University Cancer Hospital, ChongQing, Chongqing, China

🇨🇳

The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China

🇨🇳

West China Hospital, Chengdu, Sichuan, China

A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2019-09-18
Last Posted Date
2024-10-17
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
126
Registration Number
NCT04093466
Locations
🇨🇳

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2019-09-17
Last Posted Date
2020-09-03
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Registration Number
NCT04093115
© Copyright 2024. All Rights Reserved by MedPath